State Board of Administration of Florida Retirement System
AVBP icon

State Board of Administration of Florida Retirement System’s ArriVent BioPharma AVBP Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
+9,375
New +$277K ﹤0.01% 1777

Other funds holding AVBP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

State Board of Administration of Florida Retirement System's AVBP Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 9,375 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #1777 among its holdings.

47 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 9,375 shares of ArriVent BioPharma worth $326K as of Q2 2026.
  • ArriVent BioPharma was a new State Board of Administration of Florida Retirement System position in Q2 2026.
  • ArriVent BioPharma made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1777 holding.
  • 47 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.